-
公开(公告)号：US20200215266A1
公开(公告)日：2020-07-09
申请号：US16732796
申请日：2020-01-02
Applicant: Boston Scientific Scimed, Inc.
Inventor： Vijay Koya , Bryan Allen Clark , Keith R. Maile , Michael J. Kane , Jeffrey E. Stahmann , Elizabeth Mary Annoni
Abstract: A system may include an input device configured to receive a signal indicative of elevated glucose in a patient, and an electrical stimulator configured to electrically stimulate at least one skeletal muscle. The system may further include a controller operably connected to the electrical stimulator. The controller may be configured for delivering a glucose therapy in response to the signal by controlling the electrical stimulator. The system may be configured to deliver the therapy in combination with other glucose therapies, and the therapy may be titrated based on a sensed parameter or patient feedback.
-
公开(公告)号：US20190125227A1
公开(公告)日：2019-05-02
申请号：US16178872
申请日：2018-11-02
Applicant: Boston Scientific Scimed, Inc.
Inventor： Vijay Koya , Bryan Allen Clark , Kyle Harish Srivastava , Michael X. Govea , Elizabeth Mary Annoni
Abstract: A system may include an implantable structure with a plurality of electrodes attached thereto, where the implantable structure is configured to be implanted proximate to a nerve that innervates and is proximate to an organ involved with glucose control. The system may further include a controller configured for use to control which of the plurality of electrodes are modulation electrodes and which of the plurality of electrodes are sense electrodes, a modulation energy generator configured to deliver modulation energy using one or more of the modulation electrodes, and a nerve traffic sensor configured to sense nerve traffic in the nerve using one or more of the sense electrodes. The controller may be configured to determine if the delivered modulation energy captures the nerves based on the sensed neural activity.
-
Patent Agency Ranking
公开(公告)号：US20190125226A1
公开(公告)日：2019-05-02
申请号：US16178777
申请日：2018-11-02
Applicant: Boston Scientific Scimed, Inc.
Inventor： Vijay Koya , Bryan Allen Clark , Kyle Harish Srivastava , Michael X. Govea , Elizabeth Mary Annoni
Abstract: A system may include a controller operably connected to a diabetic therapy delivery system. The controller may be configured to: receive therapy inputs including a therapy input indicative of a glucose measure; determine a therapy input index using the at least one therapy input including the therapy input indicative of a glucose measure; map the determined therapy input index to a graded glucose control; and set the graded glucose control based on the mapped graded glucose control for the determined therapy input index, wherein the graded glucose control includes at least one of a neuromodulation target, a neuromodulation type, or at least one neuromodulation parameter value. The diabetic therapy delivery system may be configured to deliver the therapy for graded glucose control using the graded glucose control that was set based on the mapped graded glucose control.
-
公开(公告)号：US11304633B2
公开(公告)日：2022-04-19
申请号：US16178872
申请日：2018-11-02
Applicant: Boston Scientific Scimed, Inc.
Inventor： Vijay Koya , Bryan Allen Clark , Kyle Harish Srivastava , Michael X. Govea , Elizabeth Mary Annoni
IPC: A61N1/36 , A61N1/05 , A61B5/145 , A61B5/1486 , A61M5/172 , A61M5/142 , A61B5/00 , A61B5/1495
Abstract: A system may include an implantable structure with a plurality of electrodes attached thereto, where the implantable structure is configured to be implanted proximate to a nerve that innervates and is proximate to an organ involved with glucose control. The system may further include a controller configured for use to control which of the plurality of electrodes are modulation electrodes and which of the plurality of electrodes are sense electrodes, a modulation energy generator configured to deliver modulation energy using one or more of the modulation electrodes, and a nerve traffic sensor configured to sense nerve traffic in the nerve using one or more of the sense electrodes. The controller may be configured to determine if the delivered modulation energy captures the nerves based on the sensed neural activity.
-
公开(公告)号：US20190150851A1
公开(公告)日：2019-05-23
申请号：US16188669
申请日：2018-11-13
Applicant: Boston Scientific Scimed, Inc.
Inventor： Bryan Allen Clark , Elizabeth Mary Annoni , Sandra Nagale , Jeffrey E. Stahmann , Kyle Harish Srivastava , Mark W. Boden , Martin Phelan , George Wilfred Duval
Abstract: An example of a system for monitoring and treating a medical condition of a patient may include signal inputs to receive patient condition signals indicative of a state of inflammatory bowel disease (IBD), a signal processing circuit configured to process the patient condition signals and generate patient condition parameters indicative of the state of IBD using the processed patient condition signals, and a medical condition analyzer configured to analyze the patient condition parameters and determine the medical condition including the state of IBD using an outcome of the analysis. The patient condition parameters may include one or more physiological marker parameters each representative of a physiological marker of IBD and one or more quality of life parameters each being measure of quality of life of the patient.
-
公开(公告)号：US11419560B2
公开(公告)日：2022-08-23
申请号：US16188669
申请日：2018-11-13
Applicant: Boston Scientific Scimed, Inc.
Inventor： Bryan Allen Clark , Elizabeth Mary Annoni , Sandra Nagale , Jeffrey E. Stahmann , Kyle Harish Srivastava , Mark W. Boden , Martin Phelan , George Wilfred Duval
IPC: A61B5/00 , A61B5/024 , C07K16/24 , A61B5/11 , A61K39/00 , A61B5/08 , A61B5/113 , A61B5/0205 , G16H50/30 , A61B5/021 , A61B5/0245
Abstract: An example of a system for monitoring and treating a medical condition of a patient may include signal inputs to receive patient condition signals indicative of a state of inflammatory bowel disease (IBD), a signal processing circuit configured to process the patient condition signals and generate patient condition parameters indicative of the state of IBD using the processed patient condition signals, and a medical condition analyzer configured to analyze the patient condition parameters and determine the medical condition including the state of IBD using an outcome of the analysis. The patient condition parameters may include one or more physiological marker parameters each representative of a physiological marker of IBD and one or more quality of life parameters each being measure of quality of life of the patient.
-
公开(公告)号：US20220218241A1
公开(公告)日：2022-07-14
申请号：US17707343
申请日：2022-03-29
Applicant: Boston Scientific Scimed, Inc.
Inventor： Vijay Koya , Bryan Allen Clark , Kyle Harish Srivastava , Michael X. Govea , Elizabeth Mary Annoni
Abstract: A system may include an implantable structure with a plurality of electrodes attached thereto, where the implantable structure is configured to be implanted proximate to a nerve that innervates and is proximate to an organ involved with glucose control. The system may further include a controller configured for use to control which of the plurality of electrodes are modulation electrodes and which of the plurality of electrodes are sense electrodes, a modulation energy generator configured to deliver modulation energy using one or more of the modulation electrodes, and a nerve traffic sensor configured to sense nerve traffic in the nerve using one or more of the sense electrodes. The controller may be configured to determine if the delivered modulation energy captures the nerves based on the sensed neural activity.
-
-
-
-
-
-
Search Results
7
records
(took 0.045 seconds)
